Acciones Parnell Pharmaceuticals Holdings Ltd OTC Bulletin Board
Acciones
Farmacéuticos
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
|
Ventas 2020 | 30 M 19,84 M 18,53 M | Ventas 2021 | 34,17 M 22,6 M 21,11 M | Capitalización | 4,08 mil 2,7 mil 2,52 mil |
---|---|---|---|---|---|
Resultado Neto 2020 | -15 M -9,92 M -9,27 M | Resultado Neto 2021 | -1 M -661 mil -618 mil | VE / Ventas 2020 | 2,18 x |
Deuda neta 2020 | 56,16 M 37,15 M 34,7 M | Deuda neta 2021 | 58,89 M 38,95 M 36,38 M | VE / Ventas 2021 | 1,72 x |
P/E ratio 2020 |
-0,56
x | P/E ratio 2021 |
-
| Empleados | - |
Rendimiento 2020 * |
-
| Rendimiento 2021 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 01/02/10 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jay Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 21/12/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+21,01 % | 8910,09 M | |
+21,62 % | 3596,47 M | |
-5,56 % | 3039,38 M | |
+13,68 % | 1668,79 M | |
-5,27 % | 1227,68 M | |
-29,81 % | 1163,92 M | |
-31,11 % | 1149,82 M | |
-22,47 % | 1011,9 M | |
-12,32 % | 916 M |